Biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

CG Oncology leads the 19 biotech companies ranked by P/S ratio, at 1769, ahead of CRISPR Therapeutics (1125) and Kymera Therapeutics (264). Figures as of 18 Nov 2026, 19:59 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
First
CG Oncology1769
Median
14.3
Combined market value
ZAR 14.48T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
All sectors
Biotech
ZAR
Clear filters
Biotech companies by P/S ratio
#CompanyP/S ↓Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health Care1769ZAR 123.6BZAR 1,383.25 1.36% up 85% up United States
2CRISPR TherapeuticsCRSP · Health Care1125ZAR 68.3BZAR 703.94 1.42% up 21% down Switzerland
3Kymera TherapeuticsKYMR · Health Care264ZAR 179.1BZAR 2,098.00 0.13% down 87% up United States
4ImmunityBioIBRX · Health Care63.3ZAR 124BZAR 116.52 7.67% up 193% up United States
5ModernaMRNA · Health Care41.4ZAR 1.39TZAR 3,434.82 3.92% down 755% up United States
6Krystal BiotechKRYS · Health Care23.9ZAR 160.8BZAR 5,425.56 5.12% up 46% up United States
7Twist BioscienceTWST · Health Care21.1ZAR 137.3BZAR 2,014.24 4.03% up 340% up United States
8Adaptive BiotechnologiesADPT · Health Care16.6ZAR 79.7BZAR 492.35 0.04% down 88% up United States
9RepligenRGEN · Health Care14.9ZAR 189.9BZAR 2,971.19 5.97% up 5% up United States
10argenxARGX · Health Care14.3ZAR 1.03TZAR 16,310.32 0.43% down 4% up Belgium
11Bio-TechneTECH · Health Care9.4ZAR 197.6BZAR 1,258.18 0.21% up 26% up United States
12Halozyme TherapeuticsHALO · Health Care7.9ZAR 189.9BZAR 1,665.30 0.38% up 37% up United States
13ExelixisEXEL · Health Care7.2ZAR 289.9BZAR 1,187.90 0.31% up 63% up United States
14Gilead SciencesGILD · Health Care7.1ZAR 3.63TZAR 2,924.86 0.63% down 33% up United States
15AmgenAMGN · Health Care6.5ZAR 4.15TZAR 7,671.11 3.10% down 34% up United States
16BioNTechBNTX · Health Care6.5ZAR 358.1BZAR 1,444.28 1.55% down 16% down Germany
17Neurocrine BiosciencesNBIX · Health Care5.8ZAR 286.6BZAR 2,831.94 1.27% down 20% up United States
18QiagenQGEN · Health Care4.9ZAR 177BZAR 857.20 0.33% down 12% up Netherlands
19BiogenBIIB · Health Care3.7ZAR 639.6BZAR 4,327.21 0.19% down 49% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2874 ZAR). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies rank first by P/S ratio?

CG Oncology (1769), CRISPR Therapeutics (1125) and Kymera Therapeutics (264) are the top three of the 19 biotech companies ranked by P/S ratio as of 18 Nov 2026, 19:59 UTC.

How many biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 19 biotech companies ranked by P/S ratio have a combined market value of ZAR 14.48T as of 18 Nov 2026, 19:59 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.